Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H26ClNO4.ClH |
Molecular Weight | 440.36 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCOC(=O)COC1=CC2=C(CC[C@@H](C2)NC[C@H](O)C3=CC=CC(Cl)=C3)C=C1
InChI
InChIKey=NQIZCDQCNYCVAS-RQBPZYBGSA-N
InChI=1S/C22H26ClNO4.ClH/c1-2-27-22(26)14-28-20-9-7-15-6-8-19(11-17(15)12-20)24-13-21(25)16-4-3-5-18(23)10-16;/h3-5,7,9-10,12,19,21,24-25H,2,6,8,11,13-14H2,1H3;1H/t19-,21-;/m0./s1
Molecular Formula | C22H26ClNO4 |
Molecular Weight | 403.899 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://adisinsight.springer.com/drugs/800001600Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/1976401 | https://www.ncbi.nlm.nih.gov/pubmed/14584972
Sources: http://adisinsight.springer.com/drugs/800001600
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/1976401 | https://www.ncbi.nlm.nih.gov/pubmed/14584972
Amibegron (SR 58611A or SR 58611) is a highly selective agonist for atypical beta3-adrenoceptors. It stimulates neuronal activity in a specific area of the prefrontal cortex and also inhibits intestinal motility. Amibegron was in phase III trials worldwide for the treatment of depression and generalised anxiety disorder but development of the product was discontinued in 2008. Amibegron has been tested for its potential as a treatment for irritable bowel syndrome.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical beta-adrenoceptors in rat colon. | 1990 Aug |
|
Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depression. | 2008 Jun |
Patents
Sample Use Guides
This eight week double-blind phase III trial compared the efficacy of paroxetine with two fixed doses of amibegron (175mg or 350mg q12) in treating the symptoms of depression (NCT00385307).
In 24 healthy obese volunteers, amibegron 60 and 180 mg/day tid for 6 days and a single dose on day 7 was safe and well tolerated.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7957612
Amibegron (SR 58611A or SR 58611) increased cyclic AMP levels in membrane homogenates from rat interscapular brown adipose tissue with an EC50 of 20 nM. This compound also stimulated glycerol release from the brown fat cells, with an EC50 of 11 nM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 16 18:06:15 UTC 2022
by
admin
on
Fri Dec 16 18:06:15 UTC 2022
|
Record UNII |
N910CJ679E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Fri Dec 16 18:06:15 UTC 2022 , Edited by admin on Fri Dec 16 18:06:15 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
121888
Created by
admin on Fri Dec 16 18:06:15 UTC 2022 , Edited by admin on Fri Dec 16 18:06:15 UTC 2022
|
PRIMARY | |||
|
CHEMBL1193948
Created by
admin on Fri Dec 16 18:06:15 UTC 2022 , Edited by admin on Fri Dec 16 18:06:15 UTC 2022
|
PRIMARY | |||
|
DBSALT002941
Created by
admin on Fri Dec 16 18:06:15 UTC 2022 , Edited by admin on Fri Dec 16 18:06:15 UTC 2022
|
PRIMARY | |||
|
C97276
Created by
admin on Fri Dec 16 18:06:15 UTC 2022 , Edited by admin on Fri Dec 16 18:06:15 UTC 2022
|
PRIMARY | |||
|
N910CJ679E
Created by
admin on Fri Dec 16 18:06:15 UTC 2022 , Edited by admin on Fri Dec 16 18:06:15 UTC 2022
|
PRIMARY | |||
|
121524-09-2
Created by
admin on Fri Dec 16 18:06:15 UTC 2022 , Edited by admin on Fri Dec 16 18:06:15 UTC 2022
|
PRIMARY | |||
|
DTXSID20923848
Created by
admin on Fri Dec 16 18:06:15 UTC 2022 , Edited by admin on Fri Dec 16 18:06:15 UTC 2022
|
PRIMARY | |||
|
UU-12
Created by
admin on Fri Dec 16 18:06:15 UTC 2022 , Edited by admin on Fri Dec 16 18:06:15 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |